RMD logo

ResMed (RMD) Stock

Profile

Full Name:

ResMed Inc.

Sector:

Healthcare

Country:

United States

IPO:

02 June 1995

Indexes:

Description:

ResMed Inc. is one of the world leaders in the development, manufacturing, and marketing of medical devices and cloud software solutions for the diagnosis, treatment, and management of respiratory disorders. The company's portfolio includes a range of innovative products for a wide spectrum of respiratory diseases, including technologies used in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in hospitals and homes, headgear and other accessories, dental devices, portable oxygen concentrators, as well as cloud software information solutions for managing patient outcomes and business processes for clients and suppliers. ResMed Inc. was founded in 1989 with headquarters in San Diego, California.

Key Details

Price

$241.40

TTM Dividend Yield

0.84%(-12.50% YoY)

Annual Revenue

$4.69 B(+10.95% YoY)

Annual EPS

$6.92(+13.63% YoY)

PE Ratio

28.50(-10.12% YoY)

Beta

0.88

Events Calendar

Earnings

Next earnings date:

Apr 25, 2025

Recent quarterly earnings:

Jan 30, 2025

Recent annual earnings:

Aug 01, 2024
Dividend

Next ex-dividend date:

Feb 13, 2025

Recent ex-dividend date:

Nov 07, 2024
Splits

Next split:

N/A

Recent split:

Aug 31, 2010

Analyst ratings

Recent major analysts updates

31 Jan '25 Piper Sandler
Neutral
31 Jan '25 Needham
Hold
31 Jan '25 Keybanc
Overweight
31 Jan '25 JP Morgan
Overweight
10 Jan '25 Piper Sandler
Neutral
13 Dec '24 Stifel
Hold
25 Oct '24 RBC Capital
Sector Perform
25 Oct '24 Needham
Hold
25 Oct '24 Keybanc
Overweight
25 Oct '24 Baird
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

ResMed: Digital Health Drives Q2 Growth
ResMed: Digital Health Drives Q2 Growth
ResMed: Digital Health Drives Q2 Growth
RMD
fool.com30 January 2025

On January 30, ResMed (RMD 1.89%), a top company in sleep apnea and respiratory care, announced impressive earnings for the second quarter of fiscal 2025. The medical device firm exceeded analysts' predictions with an adjusted earnings per share (EPS) of $2.43, surpassing the $2.32 estimate, and reported revenue of $1.282 billion, which was higher than the expected $1.266 billion.

Compared to Estimates, ResMed (RMD) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, ResMed (RMD) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, ResMed (RMD) Q2 Earnings: A Look at Key Metrics
RMD
zacks.com30 January 2025

While the revenue and earnings per share (EPS) for ResMed (RMD) provide insight into its performance for the quarter ending December 2024, it could be helpful to look at how these important figures stack up against Wall Street predictions and last year's results.

ResMed (RMD) Tops Q2 Earnings and Revenue Estimates
ResMed (RMD) Tops Q2 Earnings and Revenue Estimates
ResMed (RMD) Tops Q2 Earnings and Revenue Estimates
RMD
zacks.com30 January 2025

ResMed (RMD) reported quarterly earnings of $2.43 per share, which is higher than the Zacks Consensus Estimate of $2.30 per share. This is an increase compared to earnings of $1.88 per share from the same period last year.

ResMed beats quarterly profit estimates on demand for sleep disorder devices
ResMed beats quarterly profit estimates on demand for sleep disorder devices
ResMed beats quarterly profit estimates on demand for sleep disorder devices
RMD
reuters.com30 January 2025

On Thursday, ResMed exceeded Wall Street's profit expectations for the second quarter, thanks to high demand for its devices that help treat sleep apnea, a widespread sleep issue.

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025
RMD
globenewswire.com30 January 2025

Please be aware that a webcast of ResMed's conference call can be accessed today at 4:30 p.m. ET by visiting http://investor.resmed.com.

ResMed (RMD) Earnings Expected to Grow: Should You Buy?
ResMed (RMD) Earnings Expected to Grow: Should You Buy?
ResMed (RMD) Earnings Expected to Grow: Should You Buy?
RMD
zacks.com23 January 2025

ResMed (RMD) lacks the necessary elements that could lead to a strong earnings report in the near future. Be ready for the important expectations.

Zacks.com featured highlights Chipotle Mexican Grill, ResMed and ServiceNow
Zacks.com featured highlights Chipotle Mexican Grill, ResMed and ServiceNow
Zacks.com featured highlights Chipotle Mexican Grill, ResMed and ServiceNow
RMD
Zacks13 January 2025

This week's article features Chipotle Mexican Grill, ResMed, and ServiceNow. They have been spotlighted in the Screen of The Week.

Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
RMD
zacks.com10 January 2025

Our Zacks Earnings ESP makes it simpler to identify stocks that are likely to exceed quarterly earnings predictions.

3 S&P 500 Earnings Growth Stocks to Buy in 2025: CMG, RMD, NOW
3 S&P 500 Earnings Growth Stocks to Buy in 2025: CMG, RMD, NOW
3 S&P 500 Earnings Growth Stocks to Buy in 2025: CMG, RMD, NOW
RMD
Zacks09 January 2025

Chipotle Mexican Grill, Ulta Beauty, and ServiceNow are showing impressive growth in their earnings right now.

ResMed (RMD) is an Incredible Growth Stock: 3 Reasons Why
ResMed (RMD) is an Incredible Growth Stock: 3 Reasons Why
ResMed (RMD) is an Incredible Growth Stock: 3 Reasons Why
RMD
zacks.com08 January 2025

ResMed (RMD) is likely to do better than the market because it shows strong growth in its financial performance.

FAQ

  • What is the primary business of ResMed?
  • What is the ticker symbol for ResMed?
  • Does ResMed pay dividends?
  • What sector is ResMed in?
  • What industry is ResMed in?
  • What country is ResMed based in?
  • When did ResMed go public?
  • Is ResMed in the S&P 500?
  • Is ResMed in the NASDAQ 100?
  • Is ResMed in the Dow Jones?
  • When was ResMed's last earnings report?
  • When does ResMed report earnings?
  • Should I buy ResMed stock now?

What is the primary business of ResMed?

ResMed Inc. is one of the world leaders in the development, manufacturing, and marketing of medical devices and cloud software solutions for the diagnosis, treatment, and management of respiratory disorders. The company's portfolio includes a range of innovative products for a wide spectrum of respiratory diseases, including technologies used in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in hospitals and homes, headgear and other accessories, dental devices, portable oxygen concentrators, as well as cloud software information solutions for managing patient outcomes and business processes for clients and suppliers. ResMed Inc. was founded in 1989 with headquarters in San Diego, California.

What is the ticker symbol for ResMed?

The ticker symbol for ResMed is NYSE:RMD

Does ResMed pay dividends?

Yes, ResMed pays dividends. The last payment was $0.53, with an ex-dividend date on 07 November 2024

What sector is ResMed in?

ResMed is in the Healthcare sector

What industry is ResMed in?

ResMed is in the Medical Instruments & Supplies industry

What country is ResMed based in?

ResMed is headquartered in United States

When did ResMed go public?

ResMed's initial public offering (IPO) was on 02 June 1995

Is ResMed in the S&P 500?

Yes, ResMed is included in the S&P 500 index

Is ResMed in the NASDAQ 100?

No, ResMed is not included in the NASDAQ 100 index

Is ResMed in the Dow Jones?

No, ResMed is not included in the Dow Jones index

When was ResMed's last earnings report?

ResMed's most recent earnings report was on 30 January 2025

When does ResMed report earnings?

The next expected earnings date for ResMed is 25 April 2025

Should I buy ResMed stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions